Evaluation of Patients with Insufficient Efficacy and/or Tolerability to Triptans for the Acute Treatment of Migraine: A Systematic Literature Review

A global real-world assessment of the impact on health-related quality of life and work productivity of migraine in patients with insufficient versus good response to triptan medication

(2020) Louise Lombard et al.   JOURNAL OF HEADACHE AND PAIN

Predicting treatment response using pharmacy register in migraine

(2019) Thomas Folkmann Hansen et al.   JOURNAL OF HEADACHE AND PAIN

The need for new acutely acting antimigraine drugs: moving safely outside acute medication overuse

(2019) Willem Sebastiaan van Hoogstraten et al.   JOURNAL OF HEADACHE AND PAIN

Aids to management of headache disorders in primary care (2nd edition)

(2019) T. J. Steiner et al.   JOURNAL OF HEADACHE AND PAIN

A real-world study on unmet medical needs in triptan-treated migraine: prevalence, preventive therapies and triptan use modification from a large Italian population along two years

(2019) Carlo Piccinni et al.   JOURNAL OF HEADACHE AND PAIN

Lasmiditan for the acute treatment of migraine: Subgroup analyses by prior response to triptans

(2019) Kerry Knievel et al.   CEPHALALGIA

Use and overuse of triptans in Austria – a survey based on nationwide healthcare claims data

(2018) Karin Zebenholzer et al.   JOURNAL OF HEADACHE AND PAIN

Cost Effectiveness of Reclassifying Triptans in Australia: Application of an Economic Evaluation Approach to Regulatory Decisions

(2018) Bonny Parkinson et al.   VALUE IN HEALTH

Twenty years of triptans in the United States Medicaid programs: Utilization and reimbursement trends from 1993 to 2013

(2016) Ying Xia et al.   CEPHALALGIA

Utilisation of prescription and over-the-counter triptans: a cross-sectional study in Stockholm, Sweden

(2016) Pia Frisk et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

Menstrual Migraine and Treatment Options: Review

(2016) Kasra Maasumi et al.   HEADACHE

Canadian Headache Society Guideline: Acute Drug Therapy for Migraine Headache

(2016) Irene Worthington et al.   CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES

Factors associated with frovatriptan response in patients with migraine: A prospective, observational study

(2015) Jong-Geun Seo et al.   CEPHALALGIA

Triptans in the Acute Treatment of Migraine: A Systematic Review and Network Meta-Analysis

(2015) Chris Cameron et al.   HEADACHE

Treatment Persistence and Switching in Triptan Users: A Systematic Literature Review

(2014) Andrew J. Messali et al.   HEADACHE

Revised French guidelines for the diagnosis and management of migraine in adults and children

(2014) Michel Lanteri-Minet et al.   JOURNAL OF HEADACHE AND PAIN

Outcome for headache and pain-free nonresponders to treatment of the first attack: A pooled post-hoc analysis of four randomized trials of eletriptan 40 mg

(2013) Steve H Landy et al.   CEPHALALGIA

Triptan nonresponders: Do they exist and who are they?

(2013) Michele Viana et al.   CEPHALALGIA

Examination of Unmet Treatment Needs Among Persons With Episodic Migraine: Results of the American Migraine Prevalence and Prevention (AMPP) Study

(2013) Richard B. Lipton et al.   HEADACHE

Why Triptan Treatment Can Fail: Focus on Gastrointestinal Manifestations of Migraine

(2013) Lawrence C. Newman   HEADACHE

Efficacy and tolerability of lasmiditan, an oral 5-HT1F receptor agonist, for the acute treatment of migraine: a phase 2 randomised, placebo-controlled, parallel-group, dose-ranging study

(2012) Markus Färkkilä et al.   LANCET NEUROLOGY

Efficacy and tolerability of rizatriptan for the treatment of acute migraine in sumatriptan non-responders

(2010) Jeffrey L Seeburger et al.   CEPHALALGIA

Quantifying the return of headache in triptan-treated migraineurs: An observational study

(2010) Fred Sheftell et al.   CEPHALALGIA

The serotonin transporter gene polymorphism STin2 VNTR confers an increased risk of inconsistent response to triptans in migraine patients

(2010) Salvatore Terrazzino et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Antimigraine Efficacy of Telcagepant Based on Patient's Historical Triptan Response

(2010) Tony W. Ho et al.   HEADACHE

Why pharmacokinetic differences among oral triptans have little clinical importance: a comment

(2010) Anna Ferrari et al.   JOURNAL OF HEADACHE AND PAIN

Short-Term Frovatriptan for the Prevention of Difficult-To-Treat Menstrual Migraine Attacks

(2009) JL Brandes et al.   CEPHALALGIA

Fixed-Dose Sumatriptan and Naproxen in Poor Responders to Triptans With a Short Half-Life

(2009) Ninan T. Mathew et al.   HEADACHE

Rapid Responders to Frovatriptan in Acute Migraine Treatment: Results from a Long-Term, Open-Label Study

(2009) Egilius L. H. Spierings et al.   PAIN MEDICINE

Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement

(2009) David Moher et al.   PLOS MEDICINE

Early vs. Non-Early Intervention in Acute Migraine — ‘Act When Mild (AwM)’. A Double-Blind, Placebo-Controlled Trial of Almotriptan

(2008) PJ Goadsby et al.   CEPHALALGIA

Treatment satisfaction and efficacy of the rapid release formulation of sumatriptan 100 mg tablets utilising an early intervention paradigm in patients previously unsatisfied with sumatriptan

(2008) L. C. Newman et al.   INTERNATIONAL JOURNAL OF CLINICAL PRACTICE